USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma
Male
Cancer Research
Epithelial-Mesenchymal Transition
Lung Neoplasms
Down-Regulation
Mice, Nude
Mice
03 medical and health sciences
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Animals
Humans
Mice, Inbred BALB C
0303 health sciences
Proto-Oncogene Proteins c-mdm2
Middle Aged
Prognosis
3. Good health
Lymphatic Metastasis
Carcinoma, Squamous Cell
Carcinoma, Large Cell
Female
Tumor Suppressor Protein p53
Ubiquitin Thiolesterase
Research Article
DOI:
10.1007/s13277-014-2773-4
Publication Date:
2014-12-17T13:47:51Z
AUTHORS (9)
ABSTRACT
In non-small cell lung cancer (NSCLC), both USP7 expression and p53 gene status were reported to be an indicator of poor prognosis in adenocarcinoma patients; however, its roles mechanisms squamous carcinoma large need clarified. The was examined NSCLC tumors (excluding adenocarcinoma), their corresponding non-tumorous tissues, cells. Then, the prognostic role analyzed 110 samples adenocarcinoma). Finally, proliferation, metastasis, invasion a assessed using specific vshRNA. higher tissues compared samples, accordingly, high level detected lines with HBE cell. After downregulation, H460 cells exhibited decreased metastasis/invasion vitro vivo. preliminary mechanism study indicated overexpression might regulate p53-MDM2 pathway by inducing MDM2 de-ubiquitination subsequent stabilization, which resulted upregulation Bad phosphorylation. Additionally, we also found that induce epithelial-mesenchymal transition enhance invasive ability. Clinically, significantly correlated malignant phenotype. Furthermore, 5-year overall survival patients USP7(low) than USP7(high). Multivariate analysis showed independent marker for these cancers. may properties cells, serve as molecular target.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (25)
CITATIONS (58)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....